2013Journal of Clinical Pulmonary MedicineRequires access

Observation of effect of montelukast in the treatment of patients with cough variation asthma

Wang Yu

Open publisher page 0 citations

Abstract

Objective To observe the curative effect of montelukast in the treatment of patients with cough variation asthma.Methods 96 patients with cough variation asthma were randomly divided into three groups.The group A was treated with montelukast orally 10mg once a day.The group B was given the inhalation of Salmeterol and Fluticasone(50 μg/250 μg) twice a day at morning and night.Besides,the group B was given montelukast 10 mg once a day.The group C inhaled Salmeterol and Fluticasone(50 μg/250 μg) twice a day at morning and night.The total treatment course was 8 weeks.The effect and the lung function were estimated and compared among the three groups before and 8 weeks after the treatment.Results The effect and the lung function of the three groups were all improved after the treatment(P0.05).The improvement of curative effect and lung function was more pronounced in the group B than in the rest two groups(P0.05).There was no obvious difference between the group A and the group C.Conclusion Montelukast can improve the pulmonary function and clinic symptom of CVA patients.Montelukast combined with Salmeterol and Fluticasone has a better curative effect in the treatment of CAV patients.

About this research paper

What this paper is about

Objective To observe the curative effect of montelukast in the treatment of patients with cough variation asthma.Methods 96 patients with cough variation asthma were randomly divided into three groups.The group A was treated with montelukast orally 10mg once a day.The group B was given the inhalation of Salmeterol and Fluticasone(50 μg/250 μg) twice a day at morning and night.Besides,the group B was given montelukast 10 mg once a day.The group C inhaled Salmeterol and Fluticasone(50 μg/250 μg) twice a day at morning and night.The total treatment course was 8 weeks.The effect and the lung function were estimated and compared among the three groups before and 8 weeks after the treatment.Results The effect and the lung function of the three groups were all improved after the treatment(P0.05).The improvement of curative effect and lung function was more pronounced in the group B than in the rest two groups(P0.05).There was no obvious difference between the group A and the group C.Conclusion Montelukast can improve the pulmonary function and clinic symptom of CVA patients.Montelukast combined with Salmeterol and Fluticasone has a better curative effect in the treatment of CAV patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the curative effect of montelukast in the treatment of patients with cough variation asthma.Methods 96 patients with cough variation asthma were randomly divided into three groups.The group A was treated with montelukast orally 10mg once a day.The group B was given the inhalation of Salmeterol and Fluticasone(50 μg/250 μg) twice a day at morning and night.Besides,the group B was given montelukast 10 mg once a day.The group C inhaled Salmeterol and Fluticasone(50 μg/250 μg) twice a day at morning and night.The total treatment course was 8 weeks.The effect and the lung function were estimated and compared among the three groups before and 8 weeks after the treatment.Results The effect and the lung function of the three groups were all improved after the treatment(P0.05).The improvement of curative effect and lung function was more pronounced in the group B than in the rest two groups(P0.05).There was no obvious difference between the group A and the group C.Conclusion Montelukast can improve the pulmonary function and clinic symptom of CVA patients.Montelukast combined with Salmeterol and Fluticasone has a better curative effect in the treatment of CAV patients.

Key concepts: Montelukast, Medicine, Fluticasone, Salmeterol, Inhalation, Morning, Asthma, Lung function

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation of effect of montelukast in the treatment of patients with cough variation asthma — Research Paper | ScholarLens